Rongfeng Fu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0001-5442-1028

发表论文 149 篇 · 总被引 1218 次 · h-index 20

代表论文

• Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera (2025 · Pharmacology Research & Perspectives · 被引 9)
• Timing of intravenous iron for treatment of anaemia in surgical patients: a systematic review and network meta-analysis (2025 · EClinicalMedicine · 被引 7)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Artificial intelligence-based quantitative bone marrow pathology analysis for myeloproliferative neoplasms (2025 · Haematologica · 被引 6)
• Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study) (2025 · Advanced Science · 被引 4)
• Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera (2025 · Blood Advances · 被引 3)